Original Article

Induction of Thymic HLA-DR signaling with Alpha-smooth muscle Actin expression during the second and third trimesters of gestation

Abstract

Less than 5% of prenatal thymoctes express HLA-DR before week 12 of gestation. However, the number of HLA-DR- positive cells increases during the late second and third trimesters of development. To determine the role of alpha-smooth muscle actin in fetal thymic HLA-DR signaling in different stages of development we examined and compared the immunohistochemical expression of alpha-smooth muscle actin in the myoid cells of the thymic medulla stroma in the 2 nd, and 3rd trimesters of gestation respectively, over the equivalent expression of the protein in the 1 st trimester, in relation with the appearance of HLA-DR-positive thymocytes. Our results demonstrated a quantitative difference in the second and third trimesters of development concerning the expression of alpha-smooth muscle actin in the stromal myoid cells of the thymic medulla over the equivalent expression of the protein in the first (P<0.0001, t-test). Similar changes in the above period wee found concerning the expression of HLA-DR over the first (P<0.0001, test), suggesting a direct involvement of alpha-smooth muscel acting in the sustainence of HLA-DR reactivity. Our data provide evidence that a contractile microfilament alpha-smooth muscle actin plays a pivotal role in HLA-DR expression, through interaction between medullary stromal cells and thymoctes.

Files
IssueVol 41, No 2 (2003) QRcode
SectionOriginal Article(s)
Keywords
Medullary thymocytes HLA-DR signaling Alpha-smooth muscle actin Myoid cells 2nd and 3rd trimesters of gestation

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Tamiolakis D, Venizelos J, Kotini A, Skafida P, Cheva A, Papadopoulos N. Induction of Thymic HLA-DR signaling with Alpha-smooth muscle Actin expression during the second and third trimesters of gestation. Acta Med Iran. 1;41(2):73-78.